General MedicationsOPHTHALMICGeneric
NAFAZAIR
NAPHAZOLINE HYDROCHLORIDE
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NAFAZAIR is listed in Drugs@FDA under application 088101 (ANDA).
Marketing status: Discontinued Active ingredient NAPHAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1% Sponsor PHARMAFAIR Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview NAFAZAIR is listed in Drugs@FDA under application 088101 (ANDA). Marketing status: Discontinued Active ingredient NAPHAZOLINE HYDROCHLORIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.1% Sponsor PHARMAFAIR Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.